×
About 75,796 results

ALLMedicine™ Type 1 Diabetes Center

Research & Reviews  34,929 results

"Hyperglycemia aversiveness": Investigating an overlooked problem among adults with typ...
https://doi.org/10.1016/j.jdiacomp.2021.107925
Journal of Diabetes and Its Complications; Polonsky WH, Fortmann AL et. al.

Apr 10th, 2021 - To investigate the problem of adults with type 1 diabetes (T1D) who purposefully keep their glucose levels low, and to explore contributors to, and possible impact of, this potentially dangerous phenomenon. We developed three self-report items as ...

Successful transition from insulin to sulfonylurea, on second attempt, in a 24-year-old...
https://doi.org/10.1136/bcr-2020-239973
BMJ Case Reports; Hajji S, Aljenaee K et. al.

Apr 10th, 2021 - Neonatal diabetes (NDM) is defined as diabetes that occurs in the first 6 months of life, the majority of cases are due to sporadic mutations. ATP-sensitive potassium channels located in the beta cells of the pancreas play a major role in insulin ...

A decade of improved glycemic control in young children with type 1 diabetes: A populat...
https://doi.org/10.1111/pedi.13211
Pediatric Diabetes; Sundberg F, Nåtman J et. al.

Apr 10th, 2021 - Early-onset type 1 diabetes (T1D) is associated with high risk of early cardiovascular complications and premature death. The strongest modifiable risk factor is HbA1c. Other modifiable factors, such as overweight, also increase the risk of compli...

Clinical features, biochemistry, and HLA-DRB1 status in youth-onset type 1 diabetes in ...
https://doi.org/10.1111/pedi.13209
Pediatric Diabetes; Mohammed Ibrahim TA, Govender D et. al.

Apr 10th, 2021 - To further understand clinical and biochemical features, and HLA-DRB1 genotypes, in new cases of diabetes in Sudanese children and adolescents. Demographic characteristics, clinical information, and biochemical parameters (blood glucose, HbA1c, C-...

Factors associated with treatment in primary vs specialist care: A population-based stu...
https://doi.org/10.1111/dme.14580
Diabetic Medicine : a Journal of the British Diabetic Ass... Slåtsve KB, Claudi T et. al.

Apr 9th, 2021 - To identify the proportion and characteristics of people with type 1 and 2 diabetes treated in primary, specialist and shared care. Furthermore, to identify the proportion of persons with type 2 diabetes reaching HbA1c treatment targets and the cl...

see more →

Guidelines  167 results

Caring for children and adolescents with type 1 diabetes mellitus: Italian Society for ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438223
Diabetes Research and Clinical Practice; d'Annunzio G, Maffeis C et. al.

Aug 22nd, 2020 - Our study aimed to review the impact of COVID-19 pandemia in children and adolescents with type 1 diabetes mellitus, to analyze the clinical characteristics of the infection and to propose clinical practice recommendations from the Italian Society...

Diabetic ketoacidosis: A consensus statement of the Italian Association of Medical Diab...
https://doi.org/10.1016/j.numecd.2020.06.006
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD; Lapolla A, Amaro F et. al.

Aug 10th, 2020 - Diabetic ketoacidosis (DKA) is a serious medical emergency once considered typical of type 1 diabetes (T1DM), but now reported to occur in type 2 and GDM patients as well. DKA can cause severe complications and even prove fatal. The aim of our stu...

Perioperative Management of Pediatric Patients With Type 1 Diabetes Mellitus, Updated R...
https://doi.org/10.1213/ANE.0000000000004491
Anesthesia and Analgesia; Martin LD, Hoagland MA et. al.

Nov 6th, 2019 - Approximately 1 of every 300 children in the United States has type 1 diabetes mellitus (T1D), and these patients may require anesthetics for a variety of procedures. Perioperative coordination is complex, and attention to perioperative fasting, a...

Management of immune-related adverse events in endocrine organs induced by immune check...
https://doi.org/10.1507/endocrj.EJ19-0163
Endocrine Journal; Arima H, Iwama S et. al.

Jun 27th, 2019 - Immune checkpoint inhibitors (ICIs) have become a promising treatment for advanced malignancies. However, these drugs can induce immune-related adverse events (irAEs) in several organs, including skin, gastrointestinal tract, liver, muscle, nerve,...

International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium–Glucose Cotransporter (SGLT) Inhibitors
http://care.diabetesjournals.org/content/42/6/1147
Diabetes Care; Danne,T.,et al

May 31st, 2019 - Sodium–glucose cotransporter (SGLT) inhibitors are new oral antidiabetes medications shown to effectively reduce glycated hemoglobin (A1C) and glycemic variability, blood pressure, and body weight without intrinsic properties to cause hypoglycemia...

see more →

Drugs  705 results see all →

Clinicaltrials.gov  37,519 results

Glimepiride - glimepiride tablet-Solco Healthcare U.S., LLC
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=86acdd9e-8637-43e4-8bf7-b3a123b871b8

Aug 12th, 2021 - Glimepiride tablets USP are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [see Clinical Studies (14.1) ]. Limitations of Use Glimepiride tablets USP should not be used for the trea...

"Hyperglycemia aversiveness": Investigating an overlooked problem among adults with typ...
https://doi.org/10.1016/j.jdiacomp.2021.107925
Journal of Diabetes and Its Complications; Polonsky WH, Fortmann AL et. al.

Apr 10th, 2021 - To investigate the problem of adults with type 1 diabetes (T1D) who purposefully keep their glucose levels low, and to explore contributors to, and possible impact of, this potentially dangerous phenomenon. We developed three self-report items as ...

Successful transition from insulin to sulfonylurea, on second attempt, in a 24-year-old...
https://doi.org/10.1136/bcr-2020-239973
BMJ Case Reports; Hajji S, Aljenaee K et. al.

Apr 10th, 2021 - Neonatal diabetes (NDM) is defined as diabetes that occurs in the first 6 months of life, the majority of cases are due to sporadic mutations. ATP-sensitive potassium channels located in the beta cells of the pancreas play a major role in insulin ...

A decade of improved glycemic control in young children with type 1 diabetes: A populat...
https://doi.org/10.1111/pedi.13211
Pediatric Diabetes; Sundberg F, Nåtman J et. al.

Apr 10th, 2021 - Early-onset type 1 diabetes (T1D) is associated with high risk of early cardiovascular complications and premature death. The strongest modifiable risk factor is HbA1c. Other modifiable factors, such as overweight, also increase the risk of compli...

Clinical features, biochemistry, and HLA-DRB1 status in youth-onset type 1 diabetes in ...
https://doi.org/10.1111/pedi.13209
Pediatric Diabetes; Mohammed Ibrahim TA, Govender D et. al.

Apr 10th, 2021 - To further understand clinical and biochemical features, and HLA-DRB1 genotypes, in new cases of diabetes in Sudanese children and adolescents. Demographic characteristics, clinical information, and biochemical parameters (blood glucose, HbA1c, C-...

see more →

News  2,429 results

Type 1 Diabetes and Transgender Identity: Is There a Link?
https://www.medscape.com/viewarticle/949041

Apr 8th, 2021 - The prevalence of type 1 diabetes among transgender and gender diverse patients is higher than in the general population, research suggests. This has been reported by three groups. In two studies, the cohort comprised children; in the other, older...

CDC Adds New Medical Conditions to COVID-19 High-Risk List
https://www.medscape.com/viewarticle/948445

Mar 30th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The US Centers for Disease Control and Prevention has added several new medical conditions to its list of those that predispose adults to more sev...

SGLT2 Inhibitors for T1D? Experts Debate at ENDO 2021
https://www.medscape.com/viewarticle/947963

Mar 25th, 2021 - Full disclosure: SGLT2 inhibitors are not FDA-approved for those with type 1 diabetes (T1D). But with the increased awareness of the benefits of SGLT2 inhibitors in type 2 diabetes (T2D), especially in patients with established cardiovascular and ...

1 in 5 Hospitalized With Diabetic Ketoacidosis Is Readmitted
https://www.medscape.com/viewarticle/947922

Mar 22nd, 2021 - About one in five people with type 1 diabetes in the United States hospitalized with diabetic ketoacidosis (DKA) is readmitted within 30 days, new research shows. The results from the National Readmission Database also show that deaths are higher ...

Type 1 Diabetes Raises COVID-19 Risk in Kids if A1c Is High
https://www.medscape.com/viewarticle/947857

Mar 21st, 2021 - New data on the risks of COVID-19 in children with type 1 diabetes provide reassurance, but also emphasize the importance of effective blood glucose control. Results from over 3000 children with type 1 diabetes and more than 500,000 without sugges...

see more →

Patient Education  47 results see all →